We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VEEV:NYSEVeeva Systems Inc. Analysis

Data as of 2026-03-10 - not real-time

$188.23

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Veeva Systems delivered a fourth‑quarter earnings beat, with revenue accelerating at a solid double‑digit pace and margins remaining exceptionally high, underscoring the durability of its cloud‑based franchise. Operating cash flow and free cash flow are robust, supporting the company’s ability to fund growth without reliance on external financing. The balance sheet is marked by a sizable cash pile and minimal debt, yielding a low leverage profile. Technical signals show the price trading below the 20‑day and 50‑day moving averages, indicating a short‑term bearish bias, yet the MACD histogram is positive and the RSI sits near the mid‑range, suggesting limited downside and potential for a reversal. DCF analysis places fair value well above the current market price, implying a sizable upside opportunity. The recent guidance for the upcoming quarter points to continued revenue acceleration, reinforcing the growth narrative.
Given the combination of strong fundamentals, a cash‑rich balance sheet, and an undervalued valuation relative to intrinsic estimates, the stock presents an attractive entry point for investors willing to tolerate short‑term volatility. The sector’s moderate risk profile and low regulatory headwinds further enhance the appeal, while the high 30‑day volatility and recent bearish price trend suggest a need for disciplined position sizing.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Earnings beat and strong revenue growth
  • Positive MACD histogram despite bearish price trend
  • Support level near recent lows providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust cash generation and low debt
  • DCF fair value indicating significant upside
  • Guidance pointing to continued acceleration in revenue

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • High operating and profit margins in a growing cloud SaaS niche
  • Expanding global footprint with diversified customer base
  • Sustainable competitive moat from integrated life‑sciences platform

Key Metrics & Analysis

Financial Health

Revenue Growth16.00%
Profit Margin28.44%
P/E Ratio34.6
ROE13.93%
ROA7.25%
Debt/Equity1.33
P/B Ratio4.3
Op. Cash Flow$1.4B
Free Cash Flow$1.0B
Industry P/E25.3

Technical Analysis

TrendBearish
RSI47.1
Support$168.14
Resistance$205.48
MA 20$182.58
MA 50$203.29
MA 200$257.13
MACDBullish
VolumeStable
Fear & Greed Index80.8

Valuation

Fair Value$210.97
Target Price$275.43
Upside/Downside46.33%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.67
Volatility42.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.